US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monkeypox Concept

1,674.34

+58.553.62%

Number of Gainers:3

Number of Losers:7

Number of Flat:1

PE:- -

High:1,687.64

Open:1,621.88

Low:1,621.88

Close:1,615.80

Volume:26.24M

Turnover:2.20B

Market Cap:186.83B

Float Cap:185.96B

Loading ...

Aethlon Medical trading halted, news pending

GeoVax Labs files to sell 11.9M shares of common stock for holders

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-17

BUZZ-RBC Capital Markets says Gilead's Yeztugo sales to beat Q3 estimates; shares up

Gilead Sciences Shares Hit All Time High; Last up 4.7%

THOMSON REUTERS

Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025

Gilead Sciences Chief Commercial Officer Johanna Mercier Reports Disposal of Common Shares

Emergent BioSolutions EVP Coleen Glessner Reports Disposal of Common Shares

Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing

THOMSON REUTERS

Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025

Viatris completes acquisition of Aculys Pharma

Press Release: Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia(R) in Japan and Certain Other Markets in the Asia-Pacific Region

Viatris Initiated at Buy by Truist Securities

Viatris initiated with a Buy at Truist

Gilead presents new HIV research data at European AIDS Conference

Gilead Sciences Announces Positive Phase 2 Results for Twice-Yearly Lenacapavir and Advances Long-Acting HIV Prevention and Treatment at EACS 2025

Gilead Presents New Hiv Research Data at Eacs 2025 – Driving Scientific Innovation in Treatment and Prevention

THOMSON REUTERS

Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation

Musk Receives AI Supercomputer DGX Spark Hand-Delivered by Jensen Huang

Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades'

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4583/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1674.3417,"timestamp":1760731199999,"preClose":1615.795,"halted":0,"volume":26244173,"delay":0,"changeRate":0.036234,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":58.546631,"latestTime":"10-17 16:00:00 EDT","open":1621.8799,"high":1687.6388,"low":1621.8799,"amount":2204992667.00969,"amplitude":0.040698,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.152161,"peRate":47.429132,"turnoverRate":0.009818,"increases":3,"decrements":7,"flats":0,"marketCap":186826259016.75,"floatMarketCap":185958525817.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1687.6388,"amplitude":0.040698,"preClose":1615.795,"low":1621.8799,"pbRate":"4.152161","latestPrice":1674.3417,"volume":26244173,"delay":0,"open":1621.8799,"prevYearClose":1284.7982,"prevWeekClose":1601.7455,"prevMonthClose":1540.8464,"prevQuarterClose":1540.8464,"fiveDayClose":1601.7455,"twentyDayClose":1568.002,"sixtyDayClose":1532.325,"secType":"PLATE","market":"US","turnoverRate":0.009818,"peRate":47.429132,"marketCap":186826259016.75,"floatMarketCap":185958525817.5,"timestamp":1760731199999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":3,"down":7,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576982520","title":"Aethlon Medical trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2576982520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576982520?lang=en_us&edition=fundamental","pubTime":"2025-10-18 07:50","pubTimestamp":1760745014,"startTime":"0","endTime":"0","summary":"19:50 EDT Aethlon Medical (AEMD) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aethlon-medical-trading-halted-news-pending-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4568","AEMD","BK4082"],"gpt_icon":0},{"id":"2576507064","title":"GeoVax Labs files to sell 11.9M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2576507064","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576507064?lang=en_us&edition=fundamental","pubTime":"2025-10-18 04:45","pubTimestamp":1760733913,"startTime":"0","endTime":"0","summary":"16:42 EDT GeoVax Labs (GOVX) files to sell 11.9M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/geovax-labs-files-to-sell-11-9m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/geovax-labs-files-to-sell-11-9m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4583","GOVX"],"gpt_icon":0},{"id":"2576206300","title":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-17","url":"https://stock-news.laohu8.com/highlight/detail?id=2576206300","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576206300?lang=en_us&edition=fundamental","pubTime":"2025-10-18 02:45","pubTimestamp":1760726706,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-10-17Nasdaq 100 .NDXTop PerformersPercent ChangeGilead Sciences Inc GILD.OQ+4.6%Axon Enterprise Inc AXON.OQ+3.4%CSX Corp CSX.OQ+3.0%Intuitive Surgical Inc ISRG.OQ+2.9%Workday Inc WDAY.OQ+2.8%Bottom PerformersPercent ChangeArm Holdings PLC ARM.OQ-3.3%Constellation Energy Corp CEG.OQ-2.2%ON Semiconductor Corp ON.OQ-1.7%DoorDash Inc DASH.OQ-1.7%Applovin Corp APP.OQ-1.3%The Nasdaq 100 .NDX gained 163.36 points, or 0.66%, to 24,820.60 and recorded 2 new highs and one new low. 75 stocks rose and 26 fell as advancing issues outnumbered decliners by a about a 2.9-to-1 ratio.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL5N3VY1HX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU1074936037.SGD","LU0109391861.USD","DASH","IE00B894F039.SGD","LU2298322129.HKD","IE00B3T34201.USD","BK4588","LU1868836914.USD","IE00B7SZLL34.SGD","LU0079474960.USD","CEG","LU0056508442.USD","LU2517655374.HKD","LU1548497426.USD","ON","WDAY","ARM","LU1169590202.USD","BK4023","BK4583","CSX","LU2265009873.SGD","IE00BZ9MQY76.HKD","LU1868836757.USD","LU0107464264.USD","BK4581","LU2360107325.USD","LU2517655291.USD","LU0097036916.USD","LU0096364046.USD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","GILD","LU2087621335.USD","LU1983299246.USD","LU1868836591.USD","APP","LU0786609619.USD","IE00B3S45H60.SGD","LU2517655028.SGD","LU2543165471.USD","LU0353189680.USD","SG9999015986.USD","BK4504","ISRG","BK4187","LU1868837136.USD","AXON"],"gpt_icon":1},{"id":"2576068557","title":"BUZZ-RBC Capital Markets says Gilead's Yeztugo sales to beat Q3 estimates; shares up","url":"https://stock-news.laohu8.com/highlight/detail?id=2576068557","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576068557?lang=en_us&edition=fundamental","pubTime":"2025-10-18 01:30","pubTimestamp":1760722216,"startTime":"0","endTime":"0","summary":"BUZZ-RBC Capital Markets says Gilead's Yeztugo sales to beat Q3 estimates; shares up** Shares of drugmaker Gilead GILD.O rise 5% to $123.58 ** RBC Capital Markets estimates GILD's HIV prevention drug Yeztugo could beat consensus expectations in Q3, projecting sales of $45 million compared to the Street's $35 million, driven by switching demand and early uptake** CVS's decision not to cover Yeztugo yet, along with formulary delays and continued use of generic Truvada, may limit near-term uptake, brokerage adds** RBC Capital Markets expects a Q3 beat for GILD's HIV drug Biktarvy, but continues to monitor for any potential MFN impact longer term** Company is expected to report Q3 earnings on October 30** Including session moves, stock up 33.98% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL3N3VY18C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU1674673428.USD","LU1839511570.USD","IE00BKVL7J92.USD","LU0823416689.USD","SG9999015978.USD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU2089984988.USD","BK4566","LU0289739699.SGD","LU0882574055.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00B3T34201.USD","BK4583","LU1066051498.USD","SG9999015952.SGD","LU2468319806.SGD","GILD","LU0320765992.SGD","LU1430594728.SGD","BK4532","SG9999015986.USD","BK4578","BK4568","LU1066053197.SGD","LU0234570918.USD","LU0058720904.USD","BK4585","IE0002270589.USD","LU1778281490.HKD","LU1585245621.USD","BK4139","BK4550","BK4588","LU2324357040.USD","SG9999015945.SGD","LU2087621335.USD"],"gpt_icon":0},{"id":"2576068551","title":"Gilead Sciences Shares Hit All Time High; Last up 4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576068551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576068551?lang=en_us&edition=fundamental","pubTime":"2025-10-18 01:30","pubTimestamp":1760722216,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nL3N3VY18K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU1674673691.USD","LU0109394709.USD","LU2089984988.USD","LU1066053197.SGD","LU1839511570.USD","SG9999015952.SGD","LU0114720955.EUR","SG9999015986.USD","LU1571399168.USD","LU2468319806.SGD","IE00B3T34201.USD","LU0234570918.USD","LU0320765992.SGD","SG9999015945.SGD","IE0002270589.USD","LU1778281490.HKD","BK4568","IE00B7SZLL34.SGD","LU0289739699.SGD","LU0058720904.USD","BK4585","LU1066051498.USD","LU1585245621.USD","LU0889565916.HKD","BK4532","BK4139","LU2087621335.USD","GILD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1430594728.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU0823416689.USD","BK4578","IE00BSNM7G36.USD","BK4588","LU0882574055.USD","BK4550","SG9999015978.USD","BK4583","LU1674673428.USD"],"gpt_icon":0},{"id":"2576319110","title":"Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2576319110","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576319110?lang=en_us&edition=fundamental","pubTime":"2025-10-17 19:00","pubTimestamp":1760698800,"startTime":"0","endTime":"0","summary":"TNX-801 is a live virus vaccine investigational candidate, designed to provide durable protection against mpox and smallpox TNX-801 demonstrated favorable safety, immunogenicity, and long-term protect","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/17/3168531/28908/en/Tonix-Pharmaceuticals-Presented-Data-on-TNX-801-Mpox-Vaccine-at-World-Vaccine-Congress-Europe-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HI","TNXP","BK4583","BK4161","LU2125154778.USD","BK4135","LU0128526141.USD","BK4139","LU2125154935.USD","LU0029874061.USD","CNS","LU2360032135.SGD"],"gpt_icon":0},{"id":"2576703749","title":"Gilead Sciences Chief Commercial Officer Johanna Mercier Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576703749","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576703749?lang=en_us&edition=fundamental","pubTime":"2025-10-17 09:29","pubTimestamp":1760664553,"startTime":"0","endTime":"0","summary":"Johanna Mercier, Chief Commercial Officer of Gilead Sciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nNDL4GX7Jy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IE0002270589.USD","LU1066053197.SGD","LU0109394709.USD","BK4583","LU1571399168.USD","LU0234570918.USD","LU1066051498.USD","LU0289739699.SGD","LU2089984988.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","LU2324357040.USD","LU2087621335.USD","LU1674673428.USD","BK4550","SG9999015986.USD","BK4578","IE00BKVL7J92.USD","LU1674673691.USD","LU0882574055.USD","IE00B7SZLL34.SGD","LU1430594728.SGD","LU2468319806.SGD","IE00B3T34201.USD","LU1778281490.HKD","LU1839511570.USD","LU0058720904.USD","BK4566","LU0114720955.EUR","LU0320765992.SGD","BK4568","IE00BZ1G4Q59.USD","SG9999015945.SGD","IE00B19Z3581.USD","SG9999015978.USD","BK4585","BK4139","SG9999015952.SGD","BK4588","BK4532","GILD","LU0823416689.USD"],"gpt_icon":0},{"id":"2576560773","title":"Emergent BioSolutions EVP Coleen Glessner Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576560773","media":"Reuters","labels":["shareholding","merge","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576560773?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:21","pubTimestamp":1760646119,"startTime":"0","endTime":"0","summary":"Coleen Glessner, EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emergent BioSolutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL3TWfqY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,merge,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2575741423","title":"Aethlon Medical Inc - Authorizes 1-for-10 Reverse Stock Split - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575741423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575741423?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:17","pubTimestamp":1760620624,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nFWN3VX2MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4583","AEMD","BK4568"],"gpt_icon":0},{"id":"2575413741","title":"Aethlon Medical Announces 1-for-10 Reverse Stock Split Effective October 16, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575413741","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575413741?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:16","pubTimestamp":1760620569,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc. has announced a 1-for-10 reverse stock split of its common shares, effective October 16, 2025. The company's stock will begin trading on a split-adjusted basis on the Nasdaq Capital Market starting October 20, 2025, under the existing symbol \"AEMD.\" The CUSIP number for the common stock will change to 00808Y604.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aethlon Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL21LqMj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4082","BK4583","BK4568"],"gpt_icon":0},{"id":"2575751538","title":"Viatris completes acquisition of Aculys Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2575751538","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575751538?lang=en_us&edition=fundamental","pubTime":"2025-10-16 04:35","pubTimestamp":1760560549,"startTime":"0","endTime":"0","summary":"Viatris (VTRS) announced it has acquired Aculys Pharma, a clinical stage biopharmaceutical company focused on commercializing innovative treatments...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-completes-acquisition-of-aculys-pharma-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-completes-acquisition-of-aculys-pharma-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2087621335.USD","LU1839511570.USD","BK4585","BK4588","BK4007","VTRS","BK4583"],"gpt_icon":0},{"id":"2575594407","title":"Press Release: Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia(R) in Japan and Certain Other Markets in the Asia-Pacific Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2575594407","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575594407?lang=en_us&edition=fundamental","pubTime":"2025-10-16 04:30","pubTimestamp":1760560200,"startTime":"0","endTime":"0","summary":"-- Strengthens Viatris' Presence in Japan With the Addition of Two. Innovative Assets Targeting Areas of Significant Unmet Medical Need. -- Leverages Existing Infrastructure and Expertise in Central Nervous System. \"The acquisition of Aculys Pharma leverages our deep commercial infrastructure in Japan and longstanding expertise in CNS, positioning us to bring these innovative treatments to more patients in need,\" said Corinne Le Goff, Chief Commercial Officer, Viatris. \"The addition of pitolisant and Spydia to our portfolio of innovative products is strategically aligned with our commitment to grow in areas where we can make the greatest impact and is a great example of our business development strategy designed to complement our core strengths in markets across the world.\". Under the terms of the acquisition agreement, Viatris has made an upfront payment to Aculys Pharma shareholders as consideration for the acquisition, with additional considera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4597","LU1839511570.USD","BK4081","VTRS","EMA","BK4022","ESS","BK4077","BK4232","BK4215","BK4585","R","SLE","LU2087621335.USD","BK4007","CNS","BK4588","BK4583"],"gpt_icon":0},{"id":"2575888781","title":"Viatris Initiated at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2575888781","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575888781?lang=en_us&edition=fundamental","pubTime":"2025-10-15 19:48","pubTimestamp":1760528880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VTRS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 15, 2025 07:48 ET (11:48 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","VTRS","BK4588","LU1839511570.USD","BK4585","BK4007","BK4583"],"gpt_icon":0},{"id":"2575678827","title":"Viatris initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2575678827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575678827?lang=en_us&edition=fundamental","pubTime":"2025-10-15 18:10","pubTimestamp":1760523039,"startTime":"0","endTime":"0","summary":"Truist initiated coverage of Viatris (VTRS) with a Buy rating and $15 price target While acknowledging that legacy Viatris concerns are “still prev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/viatris-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/viatris-initiated-with-a-buy-at-truist-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","VTRS","BK4007","LU1839511570.USD","BK4588","LU2087621335.USD","BK4585"],"gpt_icon":0},{"id":"2575202415","title":"Gilead presents new HIV research data at European AIDS Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2575202415","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575202415?lang=en_us&edition=fundamental","pubTime":"2025-10-15 17:10","pubTimestamp":1760519429,"startTime":"0","endTime":"0","summary":"Gilead (GILD) announced its upcoming participation in the 20th European AIDS Conference to be held in Paris, France from October 15-18. Gilead will...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gilead-presents-new-hiv-research-data-at-european-aids-conference-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gilead-presents-new-hiv-research-data-at-european-aids-conference-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","BK4532","SG9999015986.USD","IE00B3T34201.USD","LU0823416689.USD","LU2087621335.USD","SG9999015952.SGD","IE00BSNM7G36.USD","LU1839511570.USD","LU1066051498.USD","LU2089984988.USD","BK4550","BK4139","LU2468319806.SGD","LU0234570918.USD","IE00B19Z3B42.SGD","BK4578","IE0002270589.USD","LU1674673691.USD","LU2324357040.USD","LU1066053197.SGD","SG9999015978.USD","LU0114720955.EUR","BK4566","LU1430594728.SGD","LU0320765992.SGD","LU0058720904.USD","LU1571399168.USD","LU0889565916.HKD","SG9999015945.SGD","LU0882574055.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU0109394709.USD","LU1585245621.USD","BK4585","BK4583","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","GILD","LU0289739699.SGD","IE00B19Z3581.USD","LU1674673428.USD","BK4588"],"gpt_icon":0},{"id":"2575205932","title":"Gilead Sciences Announces Positive Phase 2 Results for Twice-Yearly Lenacapavir and Advances Long-Acting HIV Prevention and Treatment at EACS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575205932","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575205932?lang=en_us&edition=fundamental","pubTime":"2025-10-15 15:30","pubTimestamp":1760513419,"startTime":"0","endTime":"0","summary":"Gilead Sciences Announces Positive Phase 2 Results for Twice-Yearly Lenacapavir and Advances Long-Acting HIV Prevention and Treatment at EACS 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via Business Wire  on October 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nNDL5b02w9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0320765992.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU2087621335.USD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1066053197.SGD","LU0234570918.USD","SG9999015945.SGD","BK4578","LU0882574055.USD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU1839511570.USD","SG9999015986.USD","SG9999015978.USD","BK4550","LU1066051498.USD","LU1585245621.USD","BK4585","SG9999015952.SGD","LU1430594728.SGD","LU0823416689.USD","BK4532","LU2468319806.SGD","BK4588","BK4583","LU0889565916.HKD","IE00B3T34201.USD","LU1571399168.USD","LU2089984988.USD","BK4139","IE00B19Z3B42.SGD","LU2324357040.USD","LU0289739699.SGD","LU1778281490.HKD","BK4566","LU1674673428.USD","LU0058720904.USD","LU1674673691.USD","GILD","BK4568","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2575205536","title":"Gilead Presents New Hiv Research Data at Eacs 2025 – Driving Scientific Innovation in Treatment and Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2575205536","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575205536?lang=en_us&edition=fundamental","pubTime":"2025-10-15 15:30","pubTimestamp":1760513400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nTUA8WSRMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","IE0002270589.USD","LU0109394709.USD","LU1430594728.SGD","BK4578","LU1066051498.USD","LU2324357040.USD","LU1674673428.USD","LU2468319806.SGD","SG9999015945.SGD","IE00B3T34201.USD","LU0234570918.USD","BK4583","IE00BZ1G4Q59.USD","LU2087621335.USD","IE00BKVL7J92.USD","SG9999015952.SGD","GILD","BK4568","LU0823416689.USD","BK4566","BK4532","BK4550","LU0889565916.HKD","LU1585245621.USD","LU1674673691.USD","SG9999015986.USD","BK4585","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1839511570.USD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1571399168.USD","LU2089984988.USD","BK4588","LU0289739699.SGD","SG9999015978.USD","LU1066053197.SGD","LU0114720955.EUR","IE00B19Z3581.USD","LU0058720904.USD","BK4139","LU1778281490.HKD"],"gpt_icon":0},{"id":"2575299291","title":"Tonix Pharmaceuticals Presented an Update on Fc-modified anti-CD40L mAb, TNX-1500, at the 61st Annual Congress of the Japan Society for Transplantation","url":"https://stock-news.laohu8.com/highlight/detail?id=2575299291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575299291?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:00","pubTimestamp":1760439600,"startTime":"0","endTime":"0","summary":"CHATHAM, N.J., Oct.  14, 2025  (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated biotechnology company with marketed products and a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/14/3166024/28908/en/Tonix-Pharmaceuticals-Presented-an-Update-on-Fc-modified-anti-CD40L-mAb-TNX-1500-at-the-61st-Annual-Congress-of-the-Japan-Society-for-Transplantation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","HI","LU0029874061.USD","LU2125154778.USD","CNS","LU2125154935.USD","BK4583","LU0128526141.USD","BK4135","BK4139","LU2360032135.SGD","TNXP"],"gpt_icon":0},{"id":"1146729101","title":"Musk Receives AI Supercomputer DGX Spark Hand-Delivered by Jensen Huang","url":"https://stock-news.laohu8.com/highlight/detail?id=1146729101","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146729101?lang=en_us&edition=fundamental","pubTime":"2025-10-14 15:40","pubTimestamp":1760427632,"startTime":"0","endTime":"0","summary":"NVIDIA's official account posted on X: \"To celebrate DGX Spark beginning global shipments on Wednesday, our CEO Jensen Huang personally delivered the first batch of products to SpaceX Chief Engineer...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0882574139.USD","LU1718418525.SGD","BK4567","HK0000320264.USD","LU0323591593.USD","LU1712237335.SGD","LU0320765059.SGD","LU2543165471.USD","LU1868837300.USD","LU1435385759.SGD","LU1992135472.HKD","LU2471134796.USD","LU2505996509.AUD","HK0000320223.HKD","LU2028103732.USD","LU2452424414.USD","LU0417517546.SGD","LU2242650005.HKD","SG9999014567.USD","LU2213496289.HKD","LU0943347566.SGD","LU1267930490.SGD","LU1989764664.SGD","LU0672654240.SGD","SGXZ81514606.USD","LU2361045086.USD","SG9999000418.SGD","LU0444973449.USD","LU1934455194.USD","LU0820561818.USD","SGXZ99366536.SGD","BK4612","LU0353189763.USD","SG9999004303.SGD","LU1803068979.SGD","SG9999014898.SGD","LU2125909593.SGD","LU0444971666.USD","SG9999014906.USD","LU0210533765.USD","BK4099","LU1496350171.SGD","IE00BFSS7M15.SGD","LU0823421333.USD","BK4532","LU0158827948.USD","LU2860962120.EUR","LU0094547139.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU2125909247.SGD","HK0000306701.USD","2NVD.UK","LU0127658192.USD","LU2360032135.SGD","LU0472753341.HKD","IE00BQXX3C00.GBP","LU0276348264.USD","LU0868494708.USD","LU0820562030.AUD","LU2357305700.SGD","LU0096364046.USD","NVDX","LU2023251221.USD","IE0005OL40V9.USD","LU2463028550.USD","LU1923622291.USD","LU2168564065.EUR","SG9999014542.SGD","LU2089283258.USD","LU2168564495.EUR","BK4548","LU1548497426.USD","LU0158827781.USD","IE0004086264.USD","LU2106854487.HKD","LU2272731600.USD","LU0265550946.USD","LU0211328371.USD","LU1935043023.USD","LU2092627202.USD","IE00BMPRXN33.USD","LU1854103824.USD","LU2750360997.AUD","IE00BHPRN162.USD","IE00BJTD4V19.USD","LU1066051225.USD","LU0494093205.USD","LU1989772840.SGD","LU2420271590.USD","LU1989764748.USD","NVDU","LU0079474960.USD","LU1116320901.HKD","LU1992135399.USD","LU0289961442.SGD","LU2063271972.USD","LU0511384066.AUD","LU2271345857.HKD","LU2361044949.HKD","BK4598","LU2896262040.SGD","SG9999015341.SGD","DXYZ","IE00BDRTCR15.USD","IE00BKDWB100.SGD","LU1923622614.USD","SG9999015986.USD","SGXZ51526630.SGD","LU0342679015.USD","LU1720051017.SGD","LU2272731782.SGD","LU1935042215.USD","NVD3.UK","LU0310799852.SGD","LU1642822529.SGD","LU2326559502.SGD","LU1366192091.USD","LU0708995401.HKD","IE00BK4W5L77.USD","LU0225283273.USD","LU2413666426.HKD","LU0957791311.USD","LU2087625088.SGD","NVDD","LU1551013342.USD","DGX","LU0823414551.USD","LU1232071149.USD","LU2272731865.HKD","LU0557290698.USD","LU1821325948.USD","LU0823434740.USD","LU2097344357.USD","LU1119994496.HKD","LU0265550359.USD","IE0004445015.USD","IE0004445239.USD","LU1917777945.USD","LU2168563687.JPY","LU2237957811.SGD","LU2361044865.SGD","SG9999014880.SGD","LU1868836591.USD","LU0345770308.USD","LU1791710582.SGD","LU2237438978.USD","LU1989772923.USD","LU0157215616.USD","BK4585","LU0210536198.USD","LU0274383776.USD","LU0289960550.SGD","LU1868836757.USD","LU2462157665.USD","LU2458330169.SGD","BK4574","BK4549","LU2491050071.SGD","LU2931357623.SGD","LU2249611893.SGD","LU2403377893.USD","LU2242649171.HKD","LU1064131342.USD","LU1066053197.SGD","LU0210528500.USD","LU0198837287.USD","LU1868836914.USD","LU1316542783.SGD","LU1935043536.SGD","LU1935042488.USD","LU1623119135.USD","BK4581","LU1496350502.SGD","LU0642271901.SGD","LU1778281490.HKD","BK4614","LU0965509010.AUD","LU0251132253.USD","LU1261432733.SGD","LU2294711713.HKD","BK4550","IE0034235188.USD","IE00BWXC8680.SGD","LU0048584097.USD","LU0823414478.USD","LU0708994859.HKD","LU2746668461.USD","LU2750360641.GBP","LU2089985449.USD","IE00B775H168.HKD","BK4604","LU1280957306.USD","HK0000306685.HKD","LU2089284900.SGD","LU2461242641.AUD","SG9999002232.USD","LU0353189680.USD","LU1571399168.USD","IE00BN29S564.USD","LU0070217475.USD","LU0080751232.USD","LU1116320737.USD","IE00B7KXQ091.USD","NVIW.SI","BK4588","LU2756315318.SGD","LU2247934214.USD","IE00BJJMRY28.SGD","LU2286300806.USD","BK4551","LU1066051811.HKD","LU0061474960.USD","LU1551013425.SGD","IE00BDCRKT87.USD","IE00B19Z9505.USD","BK4579","LU0109392836.USD","IE00BMPRXQ63.HKD","LU2236285917.USD","LU2125909916.SGD","IE0034235303.USD","LU0124676726.USD","LU0238689110.USD","LU2471134879.HKD","LU1923623000.USD","LU2125154935.USD","LU1429558221.USD","LU2491049909.HKD","LU0466842654.USD","NVDS.UK","SNVD.UK","IE00BKVL7J92.USD","LU0345769128.USD","LU0310800379.SGD","LU0868494617.USD","IE00B4JS1V06.HKD","LU0154236417.USD","LU2430703178.SGD","LU2023250504.SGD","IE00BQXX3F31.USD","LU2417539215.USD","BK4583","LU0203201768.USD","LU0942090050.USD","LU0823411888.USD","BK4608","IE00BQXX3D17.EUR","LU1814569148.SGD","BK4543","LU1914381329.SGD","SG9999002224.SGD","LU0528227936.USD","LU2168564222.USD","LU1861215975.USD","LU0234570918.USD","LU0820561909.HKD","LU1145028129.USD","LU0965508806.USD","NVDA","LU2065169927.USD","LU2087621335.USD","SG9999015945.SGD","LU2322448791.USD","LU1037948541.HKD","LU1242518931.SGD","LU1951200564.SGD","LU2168564149.EUR","LU1934455863.HKD","BK4516","LU1854104046.USD","LU1791710400.SGD","LU2430703251.USD","IE00B19Z8W00.USD","3NVD.UK","LU1267930573.SGD","LU0056508442.USD","LU2357125470.USD","IE00BYXW3230.USD","SG9999018857.SGD","LU0347712357.USD","LU1323610961.USD","LU2244417387.USD","BK4529","LU2430703095.HKD","LU0097036916.USD","IE00BZ199S13.USD","LU1633808545.USD","LU0354030438.USD","LU1935042991.SGD","LU0267386448.USD","LU0072462426.USD","BK4592","LU0786609619.USD","LU0957808578.USD","LU0316494557.USD","IE00BJLML261.HKD","LU0215105999.USD","LU2290526834.HKD","LU2322448957.HKD","LU1244550577.SGD","LU2433249047.HKD","LU0077335932.USD","LU0256863811.USD","LU2250418816.HKD","LU1366333091.USD","LU1721428933.USD","LU1035775433.USD","SG9999014914.USD","LU2487616109.SGD","LU2458330243.SGD","IE00BJJMRX11.SGD","LU0234572021.USD","LU1861558580.USD","LU0109391861.USD","LU2065171311.SGD","LU0965509283.SGD","LU0823421416.USD","LU2191332357.HKD","IE00BFSS8Q28.SGD","LU1934455277.USD","LU0256863902.USD","LU0861579265.USD","LU1242518857.USD","LU2054465674.USD","IE00BSNM7G36.USD","LU2092937148.SGD","LU2265009873.SGD","IE00B3M56506.USD","NVDY","BK4141","LU1629891620.HKD","LU0354030511.USD","BK4587","LU2381873111.SGD","IE00BK4W5M84.HKD","BK4605","LU0985320562.USD","BK4554","LU0640476718.USD","NVD","LU2491050154.USD","LU2111349929.HKD","LU2471134952.CNY","LU0170899867.USD","LU1699723380.USD","LU1974910355.USD","LU2413666699.HKD","LU2506951792.HKD","IE00B1BXHZ80.USD","SGXZ23171101.USD","LU1244550494.USD","SG9999015978.USD","IE00B5949003.HKD","LU0889565833.HKD","LU2023250330.USD","IE00BD6J9T35.USD","LU1861559042.SGD","BK4527","LU2602419157.SGD","LU2360107168.USD","LU2471134523.USD","LU2237957902.USD","LU0203202063.USD","LU2756315664.SGD","LU0719512351.SGD","BK4511","LU0069063385.USD","LU2211815571.USD","LU2456880835.USD","LU0788109477.HKD","LU0081259029.USD","LU1674673691.USD","LU1868837136.USD","LU1127390331.HKD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU1804176565.USD","SG9999017495.SGD","LU1069344957.HKD","LU0308772762.SGD","SG9999001424.SGD","BK4503","IE00B1XK9C88.USD","LU1244550221.USD","LU2083900584.USD","LU1861220033.SGD","LU1861127337.USD","LU0345769631.USD","LU0266013472.USD","IE00B19Z8X17.USD","LU2360106780.USD","BK4555","LU0724617625.USD","LU2065170008.USD","LU0029864427.USD","UFO","IE00BKPKM429.USD","NVDS","LU1037948897.HKD","LU1084165304.USD","IE0004091025.USD","SG9999014559.SGD","LU0683600562.USD","NVDL","BK4533","LU0082616367.USD","BK4196","LU0096362180.USD","SG9999015358.SGD","NVD2.UK","TSYW.SI","IE0009356076.USD","LU0979878070.USD","LU2077746001.SGD","LU0964807845.USD","LU2125154778.USD","LU2505996681.GBP","IE00BMPRXR70.SGD","LU0345768740.USD","LU0345768153.USD","LU1815333072.USD","LU0823434583.USD","LU2592432038.USD","LU2065171402.SGD","LU1674673428.USD","LU0965509101.SGD","LU0289739343.SGD","LU0787776722.HKD","LU0053666078.USD","LU0006306889.USD","LU1815336760.USD","LU0689626769.HKD","LU0689472784.USD","LU0348723411.USD","LU1839511570.USD","LU2552382058.USD","LU2473716301.USD","LU2552382132.HKD","LU2125909759.SGD","IE0034235295.USD","LU0476273544.USD","LU0107464264.USD","LU1988902786.USD","LU2108987350.USD","LU1066051498.USD","LU0128525929.USD","IE00BJTD4N35.SGD","LU0106261372.USD","LU0175139822.USD","LU0211327993.USD","LU1852331112.SGD","LU1267930730.SGD","LU2552382215.SGD","TSLA","LU0057025933.USD","LU2746668974.SGD","LU0061474705.USD","SG9999014575.USD","GB00BDT5M118.USD","LU0187121727.USD","LU0345770993.USD","LU1951198990.SGD","LU1983260115.SGD","SG9999018865.SGD","SG9999015952.SGD","LU0061475181.USD","LU2097344431.USD"],"gpt_icon":1},{"id":"2575140985","title":"Gilead, Coinbase, Rocket Lab And A Tech Stock On CNBC's 'Final Trades'","url":"https://stock-news.laohu8.com/highlight/detail?id=2575140985","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575140985?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:32","pubTimestamp":1760358720,"startTime":"0","endTime":"0","summary":"On CNBC's \"Halftime Report Final Trades,\" Rob Sechan, CEO of NewEdge Wealth, named Gilead Sciences as his final trade.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/13/Close-Up-Of-Gilead-Sciences-Logo-And-Sig.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/13/Close-Up-Of-Gilead-Sciences-Logo-And-Sig.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48173116/gilead-coinbase-rocket-lab-and-a-tech-stock-on-cnbcs-final-trades","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48173116/gilead-coinbase-rocket-lab-and-a-tech-stock-on-cnbcs-final-trades","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["GILD","COIN","BK4585","SG9999015978.USD","TQQQ",".IXIC","LU1989764664.SGD","BK4550","IE00B19Z9505.USD","BK4564","SG9999015945.SGD","LU0289739699.SGD","TSYW.SI","NVIW.SI","IE00BKVL7J92.USD","LU1861558580.USD","IE00B19Z8W00.USD","QLD","USAW.SI","LU1066051498.USD","USJW.SI","LU2023250843.SGD","MNQmain","QID","LU0058720904.USD","LU2324357040.USD","BK4568","LU2023250504.SGD","RKLB","LU1861559042.SGD","LU0348723411.USD","IE00BMPRXR70.SGD","BK4097","LU1804176565.USD","NQmain","BK4139","BK4583","PANW","SG9999015952.SGD","LU1169589451.USD","PSQ","SQQQ","LU1720051108.HKD","LU1917777945.USD","LU2468319806.SGD","LU1571399168.USD","SG9999015986.USD","LU0109394709.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":55,"code":"91000000","status":"200"}]}}